NO951772D0 - Fremgangsmåte for fremstilling av taxanderivater, de således oppnådde nye taxaner samt antitumor- og antileukemipreparater inneholdende taxanene - Google Patents

Fremgangsmåte for fremstilling av taxanderivater, de således oppnådde nye taxaner samt antitumor- og antileukemipreparater inneholdende taxanene

Info

Publication number
NO951772D0
NO951772D0 NO951772A NO951772A NO951772D0 NO 951772 D0 NO951772 D0 NO 951772D0 NO 951772 A NO951772 A NO 951772A NO 951772 A NO951772 A NO 951772A NO 951772 D0 NO951772 D0 NO 951772D0
Authority
NO
Norway
Prior art keywords
taxanes
leukemia
tumor
preparation
well
Prior art date
Application number
NO951772A
Other languages
English (en)
Other versions
NO951772L (no
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO951772D0 publication Critical patent/NO951772D0/no
Publication of NO951772L publication Critical patent/NO951772L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Metallurgy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO951772A 1992-11-12 1995-05-05 Fremgangsmåte for fremstilling av taxanderivater, de således oppnådde nye taxaner samt antitumor- og antileukemipreparater inneholdende taxanene NO951772L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (fr) 1992-11-12 1992-11-12 Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR1993/001102 WO1994011547A1 (fr) 1992-11-12 1993-11-10 Procede de preparation de derives du taxane, nouveaux taxanes ainsi obtenus et les compositions antitumorales et antileucemiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO951772D0 true NO951772D0 (no) 1995-05-05
NO951772L NO951772L (no) 1995-05-05

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951772A NO951772L (no) 1992-11-12 1995-05-05 Fremgangsmåte for fremstilling av taxanderivater, de således oppnådde nye taxaner samt antitumor- og antileukemipreparater inneholdende taxanene

Country Status (15)

Country Link
EP (1) EP0667922A1 (no)
JP (1) JPH08503261A (no)
KR (1) KR950704540A (no)
AU (1) AU5425794A (no)
CA (1) CA2149240A1 (no)
CZ (1) CZ122495A3 (no)
FI (1) FI952294A (no)
FR (1) FR2697841B1 (no)
MX (1) MX9306883A (no)
NO (1) NO951772L (no)
PL (1) PL308957A1 (no)
RU (1) RU95112464A (no)
SK (1) SK60895A3 (no)
WO (1) WO1994011547A1 (no)
ZA (1) ZA938366B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (fr) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
MXPA06008293A (es) * 2004-01-22 2007-06-11 Univ Miami Formulaciones topicas de coenzima q10 y metodos de uso.
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101522A1 (ru) 2009-05-11 2012-09-28 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10)
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FI952294A0 (fi) 1995-05-11
CZ122495A3 (en) 1995-12-13
KR950704540A (ko) 1995-11-20
FR2697841B1 (fr) 1995-01-13
CA2149240A1 (fr) 1994-05-26
SK60895A3 (en) 1996-03-06
MX9306883A (es) 1995-01-31
ZA938366B (en) 1994-06-13
WO1994011547A1 (fr) 1994-05-26
FR2697841A1 (fr) 1994-05-13
PL308957A1 (en) 1995-09-04
EP0667922A1 (fr) 1995-08-23
NO951772L (no) 1995-05-05
FI952294A (fi) 1995-05-11
JPH08503261A (ja) 1996-04-09
RU95112464A (ru) 1997-02-20
AU5425794A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
NO951772D0 (no) Fremgangsmåte for fremstilling av taxanderivater, de således oppnådde nye taxaner samt antitumor- og antileukemipreparater inneholdende taxanene
NO894929D0 (no) Verktoey for behandling av undergrunnsbroenner.
FI941137A0 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI954383A (fi) Menetelmä syöpärokotteiden valmistamiseksi
NO951283D0 (no) Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
FI952585A0 (fi) Menetelmä bentsopyraaniyhdisteiden valmistamiseksi
NO891151D0 (no) Arylpiperazinylalkoksyderivater av cykliske imider, samt fremgangsmaate for fremstilling derav.
FI940775A (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI901422A0 (fi) Anordning och foerfarande foer reglering av drift av klaedestorkare.
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO900074D0 (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
FI951561A (fi) Uudet 17 -substituoidut 4-androstaanijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
AU3760489A (en) Derivatives of cyclic amp as treatment for cancer
FI931845A0 (fi) Anordning och foerfarande foer kylning av hett fast aemne i virvelbaedd
FI961178A (fi) Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi
FI906324A0 (fi) Anordning och foerfarande foer foerkromning av artiklar.
FI870089A (fi) Anordning foer reglering av doerrars oeppnande och staengande.
NO940247D0 (no) Fremgangsmaate for fremstilling av 13 -cinnamoyl baccatin III eller 10-deacetyl baccatin III
FI891100A (fi) Process och anlaeggning foer behandling av en gasstroem innehaollande sjaelvantaendbart damm.
FI892291A (fi) Menetelmä lääkeaineina käyttökelpoisten 6-fenoksimetyyli-4-hydroksitetrahydropyran-2-onien ja 6-tiofenoksimetyyli-4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojohdannaisten, suolojen ja estereiden valmistamiseksi
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
NO903329L (no) Asymmetrisk syntese av furo(3,4-c) pyridin-derivater.
AU3802093A (en) Process for the preparation of taxol and 10-deacetyltaxol
FI873082A (fi) Saett och medel foer anrikning av karbonatmineral.
NO965504D0 (no) Nye anti-tumor- og anti-leukemistoffer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene